PFIZER PHASE II TRIAL OF CP-118,954 FOR ALZHEIMER's
Executive Summary
PFIZER PHASE II TRIAL OF CP-118,954 FOR ALZHEIMER's is under way at 35 centers in 22 states and is still open for enrollment. The study's enrollment goal is 700 patients with mild to moderate Alzheimer's disease. The study is looking at slowing or alleviating some symptoms of the progressive degenerative disease.